Coot, Merinda B.

HRN: 29-11-99  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2026
MUPIROCIN 2%, 15G (TUBE)
06/16/2026
06/23/2026
TOPICAL
To Affected Area
BID
Decubitus Ulcer
Checking Initial Appropriateness 
06/25/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/25/2026
07/02/2026
IV
300mg
Q8
Sacral Ulcer
Checking Initial Appropriateness 
06/26/2026
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
06/26/2026
07/03/2026
TOPICAL
Apply Thinly
Twice Daily
Sacral Ulcer 2
Checking Initial Appropriateness 
06/28/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/28/2026
07/05/2026
IV
600mg
Q8
Sacral Ulcer
Checking Initial Appropriateness 
07/02/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/02/2026
07/08/2026
IV
600mg
Q8
Lumbosacral Wound
Checking Initial Appropriateness 
07/07/2026
MUPIROCIN 2%, 15G (TUBE)
07/07/2026
07/21/2026
TOPICAL
Apply Thinly
BID
Pressure Ulcer
Checking Initial Appropriateness 
07/14/2026
CEFTAZIDIME 1GM (VIAL)
07/14/2026
07/20/2026
IV
2g
Q8h
SSTI, Pressure Ulcer
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: